FR2042353B1 - - Google Patents
Info
- Publication number
- FR2042353B1 FR2042353B1 FR7014400A FR7014400A FR2042353B1 FR 2042353 B1 FR2042353 B1 FR 2042353B1 FR 7014400 A FR7014400 A FR 7014400A FR 7014400 A FR7014400 A FR 7014400A FR 2042353 B1 FR2042353 B1 FR 2042353B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81805769A | 1969-04-21 | 1969-04-21 | |
US81813869A | 1969-04-21 | 1969-04-21 | |
US81812569A | 1969-04-21 | 1969-04-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2042353A1 FR2042353A1 (fr) | 1971-02-12 |
FR2042353B1 true FR2042353B1 (fr) | 1974-05-24 |
Family
ID=27420121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7014400A Expired FR2042353B1 (fr) | 1969-04-21 | 1970-04-21 |
Country Status (5)
Country | Link |
---|---|
CY (1) | CY709A (fr) |
FR (1) | FR2042353B1 (fr) |
GB (1) | GB1277137A (fr) |
MY (1) | MY7300495A (fr) |
NL (1) | NL149810B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1143942B (it) * | 1980-04-23 | 1986-10-29 | Manetti & Roberts Italo Brit | Picolilammide idrata di acido isoftalico ad azione antiaggregante piastrinica antitrombinica ed anticoagulante e procedimento per la sua preparazione |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3502663A (en) * | 1969-04-21 | 1970-03-24 | Lilly Co Eli | Crystalline cephalosporin,method for its manufacture |
-
1970
- 1970-04-20 NL NL7005700A patent/NL149810B/xx not_active IP Right Cessation
- 1970-04-21 FR FR7014400A patent/FR2042353B1/fr not_active Expired
- 1970-04-21 GB GB1888370A patent/GB1277137A/en not_active Expired
-
1973
- 1973-10-01 CY CY70973A patent/CY709A/xx unknown
- 1973-12-30 MY MY7300495A patent/MY7300495A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MY7300495A (en) | 1973-12-31 |
DE2019145A1 (de) | 1970-12-03 |
DE2019145B2 (de) | 1977-02-24 |
FR2042353A1 (fr) | 1971-02-12 |
CY709A (en) | 1973-10-01 |
GB1277137A (en) | 1972-06-07 |
NL7005700A (fr) | 1970-10-23 |
NL149810B (nl) | 1976-06-15 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CL | Concession to grant licenses |